CANF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Can Fite Biopharma Ltd

Watchlist Manager

Watchlist

Price: 1.78 USD -2.73% Market Closed

Market Cap: $8.9m

C	Can Fite Biopharma Ltd AMEX:CANF	IL
	Biomind Labs Inc F:3XI	CA
	ING Bank Slaski SA F:6GF	PL
E	Euronext Athens Holding SA ATHEX:EXAE	GR
S	Sino-american Silicon Products Inc TPEX:5483	TW

Profitability Summary

Can Fite Biopharma Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 457%

Negative 3Y Average Operating Margin

-1 484%

Declining Operating Margin

-1 082% > -2 457%

Negative Net Margin

-2 427%

Negative 3Y Average Net Margin

-1 437%

Declining Net Margin

-1 017% > -2 427%

Negative Free Cash Flow Margin

-2 210%

Negative 3Y Average Free Cash Flow Margin

-1 310%

Free Cash Flow Margin is Increasing

-2 697% > -2 210%

Negative ROE

-178%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 419%

Declining ROIC

-74% > -306%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.